The well-known antidepressant Zoloft (sertraline) is about to go on sale, according to an announcement by Roszdravnadzor. The pharmaceutical company Viatris has informed Roszdravnadzor that the supply will resume.
The availability of Zoloft has been disrupted since 2022. According to one theory, the reason behind this issue is a drastic increase in global drug demand. Furthermore, the manufacturing process has been under scrutiny as reported by the media.
According to Roszdravnadzor, the reason for the shortage of Zoloft in specific areas is due to an overwhelming demand. The department claimed that there is an adequate supply of this drug in the market, and there are no indications of a scarcity. Roszdravnadzor hasn’t received any reports regarding the absence of a medication.